Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Leslie A. Royds Draper

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 15 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 15 Dec, 2021
Edits made to:
Infobox (-11 properties)
Infobox
Patent primary examiner of
‌
US Patent 11185521 Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
‌
US Patent 7732439 Biologically active methylene blue derivatives
‌
US Patent 7820679 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent
‌
US Patent 7855176 Reduced volume formulation of glatiramer acetate and methods of administration
‌
US Patent 7855197 Biologically active methylene blue derivatives
‌
US Patent 7884122 Extended release formulation and method of treating adrenergic dysregulation
‌
US Patent 7897636 Sulfamide derivative useful for the treatment of epilepsy
‌
US Patent 7915254 Biologically active methylene blue derivatives
‌
US Patent 7973057 Thalidomide analogs
‌
US Patent 7973075 Kainate receptor-selective epimeric analogs of dysiherbaine
‌
US Patent 7977383 Protective solutions for organs
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7977383 Protective solutions for organs
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7973075 Kainate receptor-selective epimeric analogs of dysiherbaine
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7973057 Thalidomide analogs
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7915254 Biologically active methylene blue derivatives
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7897636 Sulfamide derivative useful for the treatment of epilepsy
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7884122 Extended release formulation and method of treating adrenergic dysregulation
Edits on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7855197 Biologically active methylene blue derivatives
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7855176 Reduced volume formulation of glatiramer acetate and methods of administration
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits on 4 Dec, 2021
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7732439 Biologically active methylene blue derivatives
Edits on 2 Dec, 2021
Golden AI profile picture
Golden AI
edited on 2 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Dec, 2021
Edits made to:
Infobox (+2 properties)
‌

 Leslie A. Royds Draper

Infobox
Is a
Person
Person
Current Employer
United States Patent and Trademark Office
United States Patent and Trademark Office

Find more people like Leslie A. Royds Draper

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo